We are live on ! Find out more
CODX

Co-Diagnostics
CODX

45 hedge funds and large institutions have $16.3M invested in Co-Diagnostics in 2020 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,865% more capital invested

Capital invested by funds: $827K → $16.3M (+$15.4M)

1,233% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 3

350% more funds holding

Funds holding: 10 → 45 (+35)

205% more call options, than puts

Call options by funds: $5.42M | Put options by funds: $1.78M

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

3.09% more ownership

Funds ownership: 5.31% → 8.4% (+3.1%)

Holders
45
Holders Change
+35
Holders Change %
+350%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
40
Increased
2
Reduced
1
Closed
3
Calls
$5.42M
Puts
$1.78M
Net Calls
+$3.64M
Net Calls Change
+$3.64M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.13M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.08M
3
Millennium Management
Millennium Management
New York
+$600K
4
Citadel Advisors
Citadel Advisors
Florida
+$586K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$422K

Top Sellers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
-$573K
2
Barclays
Barclays
United Kingdom
-$78K
3
Renaissance Technologies
Renaissance Technologies
New York
-$14K
4
Deutsche Bank
Deutsche Bank
Germany
-$4K

CODX Hedge Fund Activity: Q1 2020 in Review

45 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q1 2020, worth a combined $16.3M — up 1,865% from $827K a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new CODX positions and 3 closed out — a net gain of 37 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $2.13M. The largest seller was HighTower Advisors, cutting an estimated $573K.

  • 45 institutional investors held Co-Diagnostics (CODX) as of Q1 2020, up from 10 in Q4 2019.
  • Funds reported $16.3M of Co-Diagnostics stock for Q1 2020, up 1,865% quarter-over-quarter.
  • 40 funds opened new Co-Diagnostics positions in Q1 2020 and 3 closed out, a net change of +37 holders.
  • The largest Co-Diagnostics buyer in Q1 2020 was Morgan Stanley, an estimated $2.13M added.
  • The largest Co-Diagnostics seller in Q1 2020 was HighTower Advisors, an estimated $573K sold.

Based on aggregated 13F filings for Q1 2020.